dc.contributor.author | Toft-Petersen, Marie | |
dc.contributor.author | Nederby, Line | |
dc.contributor.author | Kjeldsen, Eigil | |
dc.contributor.author | Kerndrup, Gitte B | |
dc.contributor.author | Brown, Gordon D | |
dc.contributor.author | Hokland, Peter | |
dc.contributor.author | Stidsholt Roug, Anne | |
dc.date.accessioned | 2016-11-24T12:28:20Z | |
dc.date.available | 2016-11-24T12:28:20Z | |
dc.date.issued | 2016-11 | |
dc.identifier | 71167812 | |
dc.identifier | 6dab8033-63e4-48f4-973c-2fc6e566d796 | |
dc.identifier | 27612176 | |
dc.identifier | 84987624325 | |
dc.identifier.citation | Toft-Petersen , M , Nederby , L , Kjeldsen , E , Kerndrup , G B , Brown , G D , Hokland , P & Stidsholt Roug , A 2016 , ' Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome ' , British Journal of Haematology , vol. 175 , no. 3 , pp. 393-401 . https://doi.org/10.1111/bjh.14270 | en |
dc.identifier.issn | 0007-1048 | |
dc.identifier.uri | http://hdl.handle.net/2164/7739 | |
dc.description | Acknowledgements The authors would like to thank Petter S. Woll, MSc, PhD, Karolinska Institutet, Stockholm, Sweden, for the kind and generous supervision of the LTC-IC experiments. We thank the FACS Core Facility at Aarhus University for access to the cell sorter and Pia S. Kristensen, Department of Haematology, Aarhus University Hospital for her excellent technical assistance conducting the FISH experiments. The Karen Elise Jensen Foundation, The Meyer Foundation, The Wellcome Trust and the Danish Cancer Society supported the study. | en |
dc.format.extent | 9 | |
dc.format.extent | 392432 | |
dc.language.iso | eng | |
dc.relation.ispartof | British Journal of Haematology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | cancer stem cells | en |
dc.subject | myelodysplastic syndrome | en |
dc.subject | hMICL | en |
dc.subject | CD371 | en |
dc.subject | LTC-IC | en |
dc.subject | R Medicine | en |
dc.subject | Wellcome Trust | en |
dc.subject.lcc | R | en |
dc.title | Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.MRC Centre for Medical Mycology | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1111/bjh.14270 | |